The AIM-HI Accelerator Fund is proud to present the 2025 BRACE Award Venture Competition in collaboration with our partner organization, the Asian Fund for Cancer Research(AFCR)!

This online application is comprised of three parts: general information, a presentation summarizing a business plan, and a brief video delivered in easy-to-understand language for a general audience. Each component must be completed and submitted before the application deadline, Saturday, March 15, 2025 at 11:55 PM EST.

Early-stage oncology companies worldwide seeking pre-seed, seed, and Series A investments are eligible to apply. The applying company must have technology ownership in place, and its technology should be able to address cancers prevalent in underserved populations.

All submitted applications will be reviewed and screened by our Selection Committee based on the quality of applications. Semi-finalists will be chosen around late April and invited to compete in front of a Judging Committee in June to select finalists who will be recognized and awarded honorariums and certificates.

An Investment Committee will conduct detailed due diligence research on the finalists to determine whether an investment will be made based on the technology platform merits, cancer patient impact, and potential for return on investment. The company that passes the due diligence process will receive up to $600,000 in investment from AIM-HI, AFCR and co-investors.

Our three-part Selection, Judging, and Investment Committees consist of world-class life sciences industry professionals, business leaders, and investors.

If the online application is not appearing in your browser below, please e-mail AIM-HI Program Manager Ella Ye at eye@aim-hiaccelerator.org to request a PDF version, and she will respond within 24 hours.